Skip to main content

Therapeutic Strategies to Overcome ALK Resistance in Cancer

  • 1st Edition, Volume 13 - January 5, 2021
  • Editor: Luc Friboulet
  • Language: English
  • Hardback ISBN:
    9 7 8 - 0 - 1 2 - 8 2 1 7 7 4 - 0
  • eBook ISBN:
    9 7 8 - 0 - 1 2 - 8 2 1 7 7 9 - 5

Therapeutic Strategies to Overcome ALK Resistance in Cancer, Volume 13, presents current strategies to improve and prolong clinical benefit in ALK driven cancers. Most patients… Read more

Therapeutic Strategies to Overcome ALK Resistance in Cancer

Purchase options

Limited Offer

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Book bundle cover eBook and print

Institutional subscription on ScienceDirect

Request a sales quote

Therapeutic Strategies to Overcome ALK Resistance in Cancer, Volume 13, presents current strategies to improve and prolong clinical benefit in ALK driven cancers. Most patients with ALK-driven cancer are sensitive to tyrosine kinase inhibitor (TKI) therapy, but resistance invariably develops. This book discusses topics such as structure and function of ALK, ALK rearranged lung cancer, resistance mechanisms to ALK TKI tumors, and novel therapeutic strategies to enhance crizotinib anti-tumor efficacy in ALCL. Additionally, it encompasses information on drug combinations to enhance ALK TKI anti-tumor efficacy in neuroblastoma and future perspectives in the field.

This book is a valuable resource for cancer researchers, clinicians and several members of biomedical field who need to understand more about how to fight ALK resistance in cancer treatment.